Daan H. van de Kerkhof

Daan H. van de Kerkhof serves as a University Lecturer in the Department of Biomedical Engineering at Eindhoven University of Technology, specializing in Chemical Biology. His academic profile demonstrates active contributions to pharmacology, toxicology, and clinical chemistry research with significant focus on biomarker development and therapeutic drug monitoring.

His research interests center on developing advanced analytical methods for clinical applications, particularly in oncology pharmacology and renal function monitoring. Key areas include mass spectrometry-based biomarker quantification, non-invasive monitoring techniques using sweat and saliva, and improving diagnostic accuracy for cancer biomarkers like neuron-specific enolase. His work bridges engineering principles with clinical medicine to create practical diagnostic solutions.

Analysis of his recent publications (2023-2025) reveals strong emphasis on translating analytical chemistry into clinical practice, with recurring themes in lung cancer diagnostics, gastrointestinal cancer treatment optimization, and continuous renal monitoring systems. His fingerprint shows significant contributions to pharmacology (100% Dabigatran research), medicine (61% Alloimmunization), and oncology (44% Lung Cancer).

Dr. van de Kerkhof actively contributes to academic instruction through the Clinical Chemistry course since 2015 and has supervised multiple student projects. His research has garnered 831 citations according to Scopus, with significant media attention including expert commentary in Oncotarget regarding NSE concentration correction for lung cancer diagnosis.

His laboratory work focuses on developing immunoaffinity mass spectrometry techniques for low-abundance protein biomarkers and non-invasive monitoring systems using sweat-based biosensors. Current projects appear directed toward personalizing chemotherapy dosing and improving diagnostic accuracy for cancer biomarkers through advanced analytical methods.